Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

OBJECTIVES: Metformin is the first-line therapy for most patients with type 2 diabetes, but the majority require treatment intensification at some stage due to the progressive nature of the disease. The 1860-LIRA-DPP-4 trial showed that liraglutide exhibited greater improvements compared with sitagl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez, Antonio, Mezquita Raya, Pedro, Ramírez de Arellano, Antonio, Briones, Teresa, Hunt, Barnaby, Valentine, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374077/
https://www.ncbi.nlm.nih.gov/pubmed/25742705
http://dx.doi.org/10.1007/s13300-015-0103-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374077/
https://www.ncbi.nlm.nih.gov/pubmed/25742705
http://dx.doi.org/10.1007/s13300-015-0103-5

Ejemplares similares